↓ Skip to main content

Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey

Overview of attention for article published in Journal of Chemotherapy, May 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey
Published in
Journal of Chemotherapy, May 2023
DOI 10.1080/1120009x.2023.2208439
Pubmed ID
Authors

Mehmet Bakırtaş, Mehmet Sinan Dal, Tuğçe Nur Yiğenoğlu, Asli Odabası Giden, Istemi Serin, Semih Başcı, Yasin Kalpakci, Serdal Korkmaz, Omer Ekinci, Murat Albayrak, Abdulkadir Basturk, Duzgun Ozatli, Mehmet Hilmi Dogu, Tuba Hacıbekiroglu, Merih Kızıl Çakar, Turgay Ulas, Mine Miskioglu, Emine Gulturk, Bulent Eser, Fevzi Altuntas

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2023.
All research outputs
#13,629,448
of 24,311,255 outputs
Outputs from Journal of Chemotherapy
#327
of 704 outputs
Outputs of similar age
#135,418
of 365,245 outputs
Outputs of similar age from Journal of Chemotherapy
#2
of 7 outputs
Altmetric has tracked 24,311,255 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 704 research outputs from this source. They receive a mean Attention Score of 2.5. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,245 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.